Mitogen-activated protein kinases (MARK) are major effector proteins, involved in cell proliferation, differentiation and apoptosis. Alterations in MARK signaling lead to development of various patho-physiological conditions. Signaling through MAPKs is predominantly controlled by growth factors, in particular, EGF. EGF receptor (EGFR) activation triggers a network of signal transduction events along with accelerated endocytosis of EGF-receptor complexes. It is proposed that endocytic trafficking regulates the intensity and duration of MARK signaling, but the mechanisms of this regulation are not understood. Moreover, both characteristics (signaling duration and intensity) have been shown to depend on the proper function of MARK scaffold proteins, yet their role in signal propagation has not been fully elucidated. The main goal of this project is to identify the role of endocytosis in activation of the MARK cascade and to define the regulatory mechanisms of endocytosis and signaling that are critical for cancer development and progression. We will analyze how EGFR activation and endocytic trafficking provides spatial and temporal control of MARK pathway signaling. We will use a quantitative method of high-resolution microscopy, fluorescence resonance energy transfer (FRET), that has been developed in our lab and has been previously used to demonstrate the presence of EGFR signaling complexes in endosomes of living cells. Here we propose a novel siRNA Knock Down And Rescue (KDAR) strategy to identify involvement of endocytic machinery in MARK activation. A number of reagents and new methodologies developed in our lab will allow us to characterize the localization of several components of MAPK1/2 module in time in living cells under conditions of physiological expression levels.

Public Health Relevance

The research proposed here will provide new insight into the specific mechanisms of regulation of the signal-transduction events by endocytic trafficking. The purpose of this research is to understand the regulatory mechanisms of the molecular cascade that affect tumor progression. Results from this study will define requirements of this intracellular signaling pathway for normal cell function, which will lead to development of new diagnostic markers work described in the Research Proposal will be conducted at the University of Colorado Health Sciences Center, Aurora Colorado

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Transition Award (R00)
Project #
Application #
Study Section
Special Emphasis Panel (NSS)
Program Officer
Spalholz, Barbara A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Kentucky
Schools of Medicine
United States
Zip Code
Jeoung, Myoungkun; Jang, Eun Ryoung; Liu, Jinpeng et al. (2016) Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics. Cell Signal 28:448-459
Rouchka, Eric C; Jeoung, Myoungkun; Jang, Eun Ryoung et al. (2016) Data set for transcriptional response to depletion of the Shoc2 scaffolding protein. Data Brief 7:770-8
Jang, Eun Ryoung; Jang, HyeIn; Shi, Ping et al. (2015) Spatial control of Shoc2-scaffold-mediated ERK1/2 signaling requires remodeling activity of the ATPase PSMC5. J Cell Sci 128:4428-41
Jang, Eun Ryoung; Shi, Ping; Bryant, Jamal et al. (2014) HUWE1 is a molecular link controlling RAF-1 activity supported by the Shoc2 scaffold. Mol Cell Biol 34:3579-93
Hannig, Vickie; Jeoung, Myoungkun; Jang, Eun Ryoung et al. (2014) A Novel SHOC2 Variant in Rasopathy. Hum Mutat 35:1290-4
Fuqua, Joshua L; Littrell, Ofelia M; Lundblad, Martin et al. (2014) Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro. Peptides 54:1-8
Jeoung, Myoungkun; Galperin, Emilia (2014) Visualizing of signaling proteins on endosomes utilizing knockdown and reconstitution approach. Methods Enzymol 534:47-63
Jeoung, Myoungkun; Abdelmoti, Lina; Jang, Eun Ryoung et al. (2013) Functional Integration of the Conserved Domains of Shoc2 Scaffold. PLoS One 8:e66067
Galperin, Emilia; Abdelmoti, Lina; Sorkin, Alexander (2012) Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cells. PLoS One 7:e36469